Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eftychia Oikonomou
Observed names:
E Oikonomou,
E. Oikonomou,
Eutyxia Oikonomou,
Oikonomou, Eftychia
Observed institutions:
Aston University,
Czech Academy of Sciences,
National Hellenic Research Foundation
OpenAlex ID:
A5009161218
BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
2011
·
Eleni Makrodouli
, Eftychia Oikonomou
, et al.
·
Molecular Cancer
·
147
PDF
BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications
2014
·
Eftychia Oikonomou
, Evangelos Koustas
, et al.
·
Oncotarget
·
109
β-catenin mutations in craniopharyngiomas and pituitary adenomas
2005
·
Eftychia Oikonomou
, Diele C. Barreto
, et al.
·
Journal of Neuro-Oncology
·
88
Tumor Heterogeneity Revealed byKRAS,BRAF, andPIK3CAPyrosequencing:KRASandPIK3CAIntratumor Mutation Profile Differences and Their Therapeutic Implications
2013
·
Vivian Kosmidou
, Eftychia Oikonomou
, et al.
·
Human Mutation
·
73
PDF
BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells
2016
·
Maria Goulielmaki
, Evangelos Koustas
, et al.
·
Oncotarget
·
66
BRAFV600E Efficient Transformation and Induction of Microsatellite Instability Versus KRASG12V Induction of Senescence Markers in Human Colon Cancer Cells
2009
·
Eftychia Oikonomou
, Eleni Makrodouli
, et al.
·
Neoplasia
·
45
PDF
Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo
2007
·
E Oikonomou
, K Kothonidis
, et al.
·
British Journal of Cancer
·
40
PDF
Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance
2011
·
Eftychia Oikonomou
, Michal Koc
, et al.
·
PLoS ONE
·
38
PDF
The TRAIL of oncogenes to apoptosis
2013
·
Eftychia Oikonomou
, Alexander Pintzas
·
BioFactors
·
37
Cancer genetics of sporadic colorectal cancer: BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies.
2006
·
Eftychia Oikonomou
, Alexandros Pintzas
·
PubMed
·
30
Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop
2008
·
Eftychia Oikonomou
, Michael Buchfelder
, et al.
·
Neuropeptides
·
26
TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors
2009
·
Eftychia Oikonomou
, Vivian Kosmidou
, et al.
·
International Journal of Cancer
·
23
A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis
2012
·
T. Joyce
, E. Oikonomou
, et al.
·
Current Cancer Drug Targets
·
21
A polymorphism in the growth hormone-releasing hormone receptor gene: Clinical significance?
2002
·
Eric F Adams
, Eftychia Oikonomou
, et al.
·
Regulatory Peptides
·
7
Meningiomas expressing and responding to cholecystokinin (CCK)
2005
·
Eftychia Oikonomou
, Ana L. Machado
, et al.
·
Journal of Neuro-Oncology
·
6
Psychiatric Hospital of Leros: a portrayal of the current situation
2023
·
Konstantinos Anargyros
, Theodoros Mavrogiannidis
, et al.
·
Psychiatriki
·
1
PDF
P483: A framework for reporting genomic newborn screening Results: Illustrative cases from ten international genomic newborn screening programs*
2026
·
Heidi Cope
, Nidhi Shah
, et al.
·
Genetics in Medicine Open
PDF
902 BRAFV600E Inhibitor Resistance Mechanisms – Co-treatment With TRAIL and PI3K Inhibitors can Sensitise to Apoptosis Resistant Colon Cancer Cells
2012
·
A. Pintzas
, E. Oikonomou
, et al.
·
European Journal of Cancer
PDF
Trail Induced Cell Death in Colon Carcinoma Cells in Vivo and in Vitro: Sensitisation by Oncogenes and by Other Therapeutics
2011
·
Eftychia Oikonomou
, Faiy H. Psahoulia
, et al.
·
National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation)
804 Bioinformatic analysis of BRAFV600E vs RASG12V signatures in colon cancer cells reveals differential regulation of cellular pathways related to MSI or EMT
2010
·
A. Pintzas
, T. Joyce
, et al.
·
European Journal of Cancer Supplements
242 RAS and BRAF oncogenes sensitise colorectal tumours to TRAIL induced apoptosis: from cell and animal models to the clinic
2010
·
A. Pintzas
, E. Oikonomou
, et al.
·
European Journal of Cancer Supplements
6126 Presence of K-RAS and BRAF oncogenic mutations sensitise colorectal tumours to TRAIL induced apoptosis: evidence from cell and animal models translated to the clinic
2009
·
A. Pintzas
, E. Oikonomou
, et al.
·
European Journal of Cancer Supplements
TRAIL synergises with targeted therapeutics to induce cell death in colon carcinoma cells in an oncogene-dependent manner
2008
·
Alexander Pintzas
, Eftychia Oikonomou
, et al.
·
Cancer Research
Culture of primary epithelial adenoma cells from familial adenomatous polyposis patients.
2008
·
Florentia Fostira
, Angela Apessos
, et al.
·
PubMed
Sensitivity to TRAIL induced apoptosis in vivo via DR5 receptor up-regulation and the role of oncogenes
2008
·
Eftychia Oikonomou
, Vivian Kosmidou
, et al.
·
National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation)
Show more works
View as search
Works count:
31
Citation count:
757
H-index:
13
I10-index:
13
Year
Topic
Type
